Dragon Pharmaceuticals Inc. Reports 2008 Third Quarter Financial Results

VANCOUVER, BRITISH COLUMBIA--(Marketwire - November 14, 2008) - Dragon Pharmaceutical Inc. ("Dragon Pharma" or the "Company") (TSX: DDD)(OTCBB: DRUG)(BBSE: DRP), a leading international pharmaceutical company, today announced its financial results for the third quarter and nine months ended September 30, 2008. Sales for the third quarter increased 54% over the same period last year to $35.48 million with gross margins of all production lines improved despite the planned overhaul of the 7-ACA and Clavulanic Acid facility during August. Net income was $1.06 million for the three months ended September 30, 2008 versus a net loss of $1.61 million for the same period of 2007.